Fundraising FoxRegeneron Ventures
Corporate VCSeed
Find your way into Regeneron Ventures
Sign up to find every way you can get introduced to Regeneron Ventures
- Your email: who you already know at Regeneron Ventures, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Regeneron Ventures team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Regeneron Ventures is a healthcare venture capital fund whose mandate spans health care broadly, with particular emphasis on biotechnology, medical devices, tools, and enabling technologies. It operates independently from its single, exclusive limited partner, Regeneron Pharmaceuticals, while sharing that company's patient-centric, science-based mission and values. Investment decisions are grounded in the quality of the people, science, and data behind a company, and the fund favors breakthrough innovation while tolerating risk and uncertainty. It takes an open-minded, questioning approach and recognizes that each company is idiosyncratic and should follow its own path. The firm aims to help portfolio companies turn great ideas into great products that benefit patients.
Source: firm website, verified Oct 2, 2026.
Frequently asked questions
- What stage does Regeneron Ventures invest at?
- Regeneron Ventures invests at the Seed stage.
- What sectors does Regeneron Ventures focus on?
- Regeneron Ventures focuses on Biotech, Deep Tech, Healthtech, Medical Devices.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.